WESTMINSTER RADAR
Search
My MPs
Menu

Question follow-through · 4391

Cancer: Vaccination

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 May 2026 to Question 506 on Cancer: Vaccination, whether there will be further (a) webinars and (b) other engagement events for interested pharmaceutical companies in 2

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
29 May 2026
Target answer date
2 Jun 2026
Answer
4 Jun 2026 · 6 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 29 May 2026

    Question tabled

    To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 May 2026 to Question 506 on Cancer: Vaccination, whether there will be further (a) webinars and (b) other engagement events for interested pharmaceutical companies in 2

  2. 2 Jun 2026

    Target answer date

    Date supplied by the official written-questions record.

  3. 4 Jun 2026

    Answer published

    The Cancer Vaccines Launch Pad (CVLP) is open to supporting immunotherapy trials for all cancer types, including brain cancer, and welcomes conversations with interested companies.NHS England hosted a webinar in 2025, and representatives from 12 pharmaceu...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Brain: Injuries

1 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether he plans to adopt the draft Acquired Brain Injury Action Plan, published on 4 May 2026, before 1 July 2026.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Pharmacy: Finance

1 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of his department producing and publishing a long-term financial sustainability plan for community pharmacy in partnership with the communi

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Medicine: Research

3 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether there will be measures to increase the recruitment and retention of clinicians to support medical research in the ten year workforce plan.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Brain: Tumours

3 Jun 2026 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of access scanner capacity to support increased brain tumour research.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Brain: Tumours

3 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the number of research clinicians supporting levels of brain tumour research.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Brain Cancer: Medical Treatments

3 Jun 2026 · To ask the Secretary of State for Health and Social Care, what recent discussions he has had with (a) MHRA and (b) NICE on OPTUNE treatment for brain cancer patients.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Leukaemia: Diagnosis

9 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of delays in access to Full Blood Count testing on the timely diagnosis of leukaemia.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Meningitis: Vaccination

16 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of expanding eligibility for the MenB vaccination programme to students aged 26 and older.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Diethylstilbestrol: Side Effects

23 Jun 2026 · To ask the Secretary of State for Health and Social Care, if he would hold a public inquiry into the effects of diethylstilbestrol.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Diethylstilbestrol

23 Jun 2026 · To ask the Secretary of State for Health and Social Care, what training healthcare professionals are given on the impacts of diethylstilbestrol.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Cerebrospinal Fluid: Medical Treatments

8 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps he has taken to help improve NHS (a) diagnosis and (b) treatment pathways of patients suffering a cerebrospinal fluid (CSF) leak.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Cerebrospinal Fluid: Medical Treatments

8 Jul 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of developing a nationally coordinated (a) diagnosis pathway and (b) specialist service for patients with a suspected cerebrospinal fluid (CSF) l